| 000 | 01383 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250517110355.0 | ||
| 264 | 0 | _c20171023 | |
| 008 | 201710s 0 0 eng d | ||
| 022 | _a1938-0682 | ||
| 024 | 7 |
_a10.1016/j.clgc.2016.05.011 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aParikh, Rahul A | |
| 245 | 0 | 0 |
_aTyrosine Kinase and Mammalian Target of Rapamycin Inhibitors in the Treatment of Advanced Renal Cell Carcinoma: Practical Clinical Implications of Pharmacologic Features. _h[electronic resource] |
| 260 |
_bClinical genitourinary cancer _c02 2017 |
||
| 300 |
_a7-22 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aCarcinoma, Renal Cell _xdrug therapy |
| 650 | 0 | 4 | _aClinical Decision-Making |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aPrecision Medicine |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aTOR Serine-Threonine Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aAppleman, Leonard J | |
| 700 | 1 | _aBeumer, Jan H | |
| 700 | 1 | _aMatczak, Ewa | |
| 700 | 1 | _aChu, Edward | |
| 773 | 0 |
_tClinical genitourinary cancer _gvol. 15 _gno. 1 _gp. 7-22 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.clgc.2016.05.011 _zAvailable from publisher's website |
| 999 |
_c26280130 _d26280130 |
||